Market Cap

Ipsen SA Market Capitalization:

€8.30 Billion

EUR as of Jan. 1, 2023

US$8.84 Billion

business Ipsen SA Company Profile

Ipsen SA Main Stock Listing

show_chart Euronext: IPN

Market Capitalization History of Ipsen SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $87.64 B
Zoetis Inc. $68.38 B
Takeda Pharmaceutical Company Limited $46.57 B
Eisai Co. Ltd $17.23 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of Ipsen SA market cap

Date Market Cap YoY Change
Jan. 1, 2023 €8.30 B 18.42%
Jan. 1, 2022 €7.00 B 19.78%
Jan. 1, 2021 €5.85 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Ipsen SA Categories

France languages Healthcare languages Drug Manufacturers—Specialty & Generic
France Healthcare France Drug Manufacturers—Specialty & Generic

Stocks & Indices

Ipsen SA has the following listings and related stock indices.


Stock: Euronext: IPN

Stock: OTC: IPSEY

Stock: FSX: I7G

Stock: OTC: IPSEF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.